Acute attenuation of glycocalyx barrier properties increases coronary blood volume independently of coronary flow reserve

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 2, 2010, Pages

  Brands, Judith ^a   Spaan, Jos A E ^b   Van Den Berg, Bernard M ^a   Vink, Hans ^a,b   VanTeeffelen, Jurgen W G E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adenosine; Blood flow; Coronary circulation; Indicator dilution

Indexed keywords

ADENOSINE; DEXTRAN; HYALURONIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; CELL LABELING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; ERYTHROCYTE; FEMALE; GLYCOCALYX; GOAT; HEART; INDICATOR DILUTION CURVE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ADENOSINE; ANIMALS; BLOOD VOLUME; CELL MEMBRANE; CORONARY VESSELS; FEMALE; GLYCOCALYX; GOATS; HYALURONOGLUCOSAMINIDASE; MODELS, ANIMAL; MODELS, BIOLOGICAL; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 74949142850     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01306.2008     Document Type: Article

References (45)

1. Bassingthwaighte JB, Knopp TJ, Anderson DU. Flow estimation by indicator dilution (bolus injection). Circ Res 27: 277-291, 1970.
2. Bogaard JM, Smith SJ, Versprille A, Wise ME, Hagemeijer F. Physiological interpretation of the skewness of indicator-dilution curves; theoretical considerations and a practical application. Basic Res Cardiol 79: 479-493, 1984.
3. Brands J, VanTeeffelen JW, Van den Berg BM, Vink H. Role for glycocalyx perturbation in atherosclerosis development and associated microvascular dysfunction. Future Lipidol 2: 527-534, 2007.
4. Bruegger D, Jacob M, Rehm M, Loetsch M, Welsch U, Conzen P, Becker BF. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 289: H1993-H1999, 2005.
5. Cabrales P, Vazquez BY, Tsai AG, Intaglietta M. Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 102: 2251-2259, 2007.
6. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 356: 830-840, 2007.
7. Crystal GJ, Downey HF, Bashour FA. Small vessel and total coronary blood volume during intracoronary adenosine. Am J Physiol Heart Circ Physiol 241: H194-H201, 1981.
8. Desjardins C, Duling BR. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol Heart Circ Physiol 258: H647-H654, 1990.
9. Feigl EO. Coronary physiology. Physiol Rev 63: 1-205, 1983.
10. Henry CB, Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol Heart Circ Physiol 277: H508-H514, 1999.
11. Hirche H, Lochner W. Measurement of the blood flow and blood filling of the coronary vascular bed with the test substance injection method on the anesthetized dog with closed thorax [in German]. Pflügers Arch Gesamte Physiol Menschen Tiere 274: 624-632, 1962.
12. Hoffman EA, Ritman EL. Intramyocardial blood volume-implications for analysis of myocardial mechanical characteristics via in vivo imaging of the heart. In: Activation, Metabolism and Perfusion of the Heart, edited by Sideman S and Beyar R. Dordrecht, The Netherlands: Martinus Nijhoff, 1987, p. 421-431.
13. Huxley VH, Williams DA. Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. Am J Physiol Heart Circ Physiol 278: H1177-H1185, 2000.
14. Kahler E, Waller C, Rommel E, Belle V, Hiller KH, Voll S, Bauer WR, Haase A. Perfusion-corrected mapping of cardiac regional blood volume in rats in vivo. Magn Reson Med 42: 500-506, 1999.
15. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 109: 568-572, 2004.
16. Kassab GS, Lin DH, Fung YC. Morphometry of pig coronary venous system. Am J Physiol Heart Circ Physiol 267: H2100-H2113, 1994.
17. Kaul S. Evaluating the "no reflow" phenomenon with myocardial contrast echocardiography. Basic Res Cardiol 101: 391-399, 2006.
18. Kaul S. Microbubbles and ultrasound: a bird's eye view. Trans Am Clin Climatol Assoc 115: 137-148, 2004.
19. Kiyooka T, Hiramatsu O, Shigeto F, Nakamoto H, Tachibana H, Yada T, Ogasawara Y, Kajiya M, Morimoto T, Morizane Y, Mohri S, Shimizu J, Ohe T, Kajiya F. Direct observation of epicardial coronary capillary hemodynamics during reactive hyperemia and during adenosine administration by intravital video microscopy. Am J Physiol Heart Circ Physiol 288: H1437-H1443, 2005.
20. Klitzman B, Duling BR. Microvascular hematocrit and red cell flow in resting and contracting striated muscle. Am J Physiol Heart Circ Physiol 237: H481-H490, 1979.
21. Ljungstrom KG. Dextran 40 therapy made safer by pretreatment with dextran 1. Plast Reconstr Surg 120: 337-340, 2007.
22. Megens RT, Reitsma S, Schiffers PH, Hilgers RH, De Mey JG, Slaaf DW, oude Egbrink MG, van Zandvoort MA. Two-photon microscopy of vital murine elastic and muscular arteries. Combined structural and functional imaging with subcellular resolution. J Vasc Res 44: 87-98, 2007.
23. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 6: 731-744, 1954.
24. Mochizuki S, Vink H, Hiramatsu O, Kajita T, Shigeto F, Spaan JA, Kajiya F. Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release. Am J Physiol Heart Circ Physiol 285: H722-H726, 2003.
25. Morgenstern C, Holjes U, Arnold G, Lochner W. The influence of coronary pressure and coronary flow on intracoronary blood volume and geometry of the left ventricle. Pflügers Arch 340: 101-111, 1973.
26. Nieuwdorp M, Meuwese MC, Mooij HL, Ince C, Broekhuizen LN, Kastelein JJ, Stroes ES, Vink H. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol 104: 845-852, 2008.
27. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Stroes ES, Vink H. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55: 1127-1132, 2006.
28. Pahakis MY, Kosky JR, Dull RO, Tarbell JM. The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress. Biochem Biophys Res Commun 355: 228-233, 2007.
29. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bar F, Hoorntje J, Koolen J, Wijns W, de Bruyne B. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 49: 2105-2111, 2007.1
30. Platts SH, Duling BR. Adenosine A3 receptor activation modulates the capillary endothelial glycocalyx. Circ Res 94: 77-82, 2004.
31. 2A receptor activation. Am J Physiol Heart Circ Physiol 284: H2360-H2367, 2003.
32. Rubio-Gayosso I, Platts SH, Duling BR. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 290: H2247-H2256, 2006.
33. Spaan JA, Breuls NP, Laird JD. Forward coronary flow normally seen in systole is the result of both forward and concealed back flow. Basic Res Cardiol 76: 582-586, 1981.
34. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res 92: 592-594, 2003.
35. van der Ploeg CP, Dankelman J, Spaan JA. Functional distribution of coronary vascular volume in beating goat hearts. Am J Physiol Heart Circ Physiol 264: H770-H776, 1993.
36. van Haaren PM, VanBavel E, Vink H, Spaan JA. Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. Am J Physiol Heart Circ Physiol 285: H2848-H2856, 2003.
37. VanTeeffelen J, Constantinescu A, Brands J, Spaan JA, Vink H. Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties. J Physiol 586: 3207-3218, 2008.
38. VanTeeffelen JW, Brands J, Jansen C, Spaan JA, Vink H. Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice. Hypertension 50: 261-267, 2007.
39. VanTeeffelen JW, Brands J, Stroes ES, Vink H. Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc Med 17: 101-105, 2007.
40. VanTeeffelen JW, Dekker S, Fokkema DS, Siebes M, Vink H, Spaan JA. Hyaluronidase treatment of coronary glycocalyx increases reactive hyperemia but not adenosine hyperemia in dog hearts. Am J Physiol Heart Circ Physiol 289: H2508-H2513, 2005.
41. van Zutphen LF, Baumans V, Beynen AC. (Editors). Handboek proefdierkunde. Proefdieren, dierproeven, alternatieven en ethiek. Maarssen, The Netherlands: Elsevier, 2003.
42. Vink H, Duling BR. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278: H285-H289, 2000.
43. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79: 581-589, 1996.
44. Waller C, Kahler E, Hiller KH, Hu K, Nahrendorf M, Voll S, Haase A, Ertl G, Bauer WR. Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation: MR imaging in vivo with use of a spin-labeling technique. Radiology 215: 189-197, 2000.
45. Ziegler WH, Goresky CA. Transcapillary exchange in the working left ventricle of the dog. Circ Res 29: 181-207, 1971.